試す 金 - 無料
3 trends to drive and shape the future of digital health
BioSpectrum Asia
|BioSpectrum Asia July 2021
A year on, the effects of the COVID-19 pandemic on the world continue to be profound. More than 90 per cent of global executives polled by McKinsey and Company believe COVID-19 will fundamentally change their businesses, and 85 per cent predict lasting changes in customers’ preferences. Being on the frontlines of the fight against COVID-19 has placed unparalleled demands on the healthcare industry no less – and quite possibly more – than any other sector.
-
Chintan Desai, ASEAN CEO, GE Healthcare, Singapore
Healthcare systems across the world were initially caught off-guard when tasked with this unprecedented crisis, which required the urgent mobilisation of resources and affected the whole population.
Unfortunately, the fight is still far from over. In recent weeks, new, more contagious variants of the virus have emerged in countries such as India, the United Kingdom, and South Africa. These intractable variants have spread rapidly across the region sending countries into another round of lockdowns, outpacing the global vaccination programme determined to be the best weapon in fighting the pandemic.
Global social distancing, infection control, and lockdown measures have created a plethora of challenges for the healthcare industry as it looks to tackle the influx of patients while continuing to deliver ongoing care that remains critical. However, for an industry that thrives through constant discovery, the eventual speed and scale of its response to COVID-19 has been nothing short of remarkable.
The pandemic has proved to be a powerful catalyst in bringing forward the industry’s digitalisation. We are now seeing the convergence of digital technologies with healthcare, to make medicine more personalised and precise.
As the situation evolves, it is important we continue to invest in building new capabilities today so that we have the capacity to deal with the emergencies of tomorrow. Here are three trends I believe will permanently drive and shape the way healthcare is delivered and received, for the future of digital health.
1. Accelerating precision health by leveraging digital technology
このストーリーは、BioSpectrum Asia の BioSpectrum Asia July 2021 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
BioSpectrum Asia からのその他のストーリー
BioSpectrum Asia
Waters launches charge detection mass spectrometry technology
US-based Waters Corporation has unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched measurement and characterisation for the broadest range of mega-mass biomolecules central to next-generation therapeutics and structural biology.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Chulalongkorn University launches Thailand's first master's programme in Nurse Anesthesia
The Faculty of Nursing, Chulalongkorn University, has officially launched the \"Master of Nursing Science Programme in Nurse Anesthesia\" - the first of its kind in Thailand.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
WHO strengthens coordination for NTD programmes and supply chain delivery
The World Health Organization (WHO), together with health ministries, pharmaceutical donours, implementing partners and technical support platforms, is strengthening coordination for neglected tropical disease (NTD) programmes and supply chain delivery, through three major back-to-back meetings in Geneva.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
All-in-one coronavirus vaccines to save millions in future pandemics
A new study reveals that vaccines designed to protect against a wide range of coronaviruses could dramatically reduce deaths and economic disruption and limit the need for lockdowns in the event of another global coronavirus pandemic.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
NTU in Singapore introduces Master of Science course in Chinese Medicine
From 2026, Nanyang Technological University (NTU) in Singapore will start offering a Master of Science in Chinese Medicine to develop highly skilled postgraduates with advanced expertise in both the theoretical foundations and practical applications of Chinese medicine.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
ProSpecBio launches Activin-A recombinant protein for brain injury research
Israel-based ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, has announced the launch of its latest product: CHO cell-derived recombinant Activin-A, now available for immediate delivery worldwide.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
PAHO publishes guide for designing AI instructions in public health
The Pan American Health Organization (PAHO) has launched a new guide providing practical advice on how to create Artificial Intelligence (AI) prompts that generate reliable, relevant, and culturally appropriate content across diverse contexts.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Prerna launches India's first MicroRNA based blood test for breast cancer screening
Precision RNA Biotech (Prerna), a healthcare startup from Hyderabad, India has announced the launch of Cantel, India's first microRNA-based blood test for breast cancer screening.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Poly Medicure announces acquisition of Citieffe Group for Rs 324 Cr
India-based medtech firm Poly Medicure has announced signing of a definitive agreement to acquire 100 per cent stake in Medistream SA (Group) consisting of Citieffe SRL and its step-down subsidiaries in USA & Mexico, at an Enterprise Value of Rs 324 crore (EUR 31 million).
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Sumitomo, Novo Nordisk to co-promote obesity drug Wegovy in Japan
Sumitomo Pharma and Novo Nordisk Pharma have entered into a co-promotion agreement in Japan for Wegovy Subcutaneous Injection, a once-weekly subcutaneous injection formulation of GLP-1 receptor agonist indicated for the treatment of obesity disease.
1 min
BioSpectrum Asia Nov 2025
Translate
Change font size
